Fundraising Fox
🦊/People
Sign in

Geoffrey Smith

Investor

Managing Partner at Digitalis Ventures · Board director at Grobio

New York, New York

Writes $100K – $10M checks · typically $1.5M

Find your path to Geoffrey

294 people in our graph share verified history with Geoffrey — schools, employers, funds. One of them is your warm intro.

Tristan HuntunlockedGeoffrey: together at Digitalis Commons (2024–2026)
Geoffrey: together at The Rockefeller University
×9Geoffrey: together at Williams College
Geoffrey: together at The Jackson Laboratory

About

Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDeep TechDigital HealthHardwareHealthtechMedical Devices

Board director at Grobio

Intro paths

→

In turn, Geoffrey can intro founders to Grobio's investors below.

Grobio's investors · 8

Atlas VentureCambridge · $500K – $1M checks · since 2024Digitalis VenturesNew York · $100K – $10M checksDreamers VCEl Segundo · $500K – $5M checksInnovation EndeavorsPalo Alto · $1M – $15M checksLeaps by BayerLeverkusen · since 2021OS FundPark Ridge · $1M – $2M checksREDMILESan Francisco · since 2021Rising TidePacifica

Co-founders at Grobio

DJ
Daniel J MandellChief Executive Officer

Experience

  1. Digitalis VenturesFounder/Managing Partnercurrent2016 — presentNew York City Metropolitan Area
  2. Digitalis CommonsFounder/Chairmancurrent2019 — present
  3. Digitalis LabsFounder/Director of Researchcurrent2025 — presentNew York, New York, United States
  4. Partnership Fund for New York CityDirectorcurrent2026 — presentNew York, New York, United States
  5. Salzburg Global SeminarDirectorcurrent2024 — present
  6. The Jackson LaboratoryTrusteecurrent2017 — present
  7. Icahn School of Medicine at Mount SinaiDirector, Mount Sinai Institute of Technology2013 — 2014New York, NY
  8. Icahn School of Medicine at Mount SinaiProfessor, Population Health Science and Policy2012 — 2014New York, NY
  9. The Rockefeller UniversityVisiting Scholar2006 — 2014New York, New York, United States

Skills & more

Lifesciences27Biotechnology38Drug Discovery18Clinical Trials13Venture Capital51Management15Oncology4Infectious Diseases4Entrepreneurship12Technology Transfer7Pharmaceutical Industry4Cancer4
+9 moreCommercializationClinical DevelopmentCell BiologyGeneticsCell CultureLife SciencesStrategyStart-upsBusiness Strategy

From Geoffrey's professional profile.

Investments

Investor

ARYx TherapeuticsCara TherapeuticsCoferonElemental MachinesGirihletGRO BiosciencesRejuvenate BioSchoolCareTargAnoxTerray Therapeutics

Per curated public sources.

Colleagues at Digitalis Ventures

Amit Bansal
Partner at Digitalis Ventures
Ben Jacobs
Partner at Digitalis Ventures
Bo Stewart
Associate at Digitalis Ventures
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Dylan Henderson
Accounting Manager at Digitalis Ventures
Haiming Chen
Senior Accounting Manager at Digitalis Ventures

Network8

Ameena El-Bibany
Venture Partner at Page One Ventures
Amit Bansal
Partner at Digitalis Ventures
Charles K. Herman
Venture Partner at Digitalis Ventures
Chris Picardo
Partner at Madrona investing at the intersection of life science and computer science, plus consumer tech and Web3
Cindy Cole
Technical Partner at Digitalis Ventures
Dac Nguyen
Technical Partner at Digitalis Ventures
Drew Taylor
Partner at Digitalis Ventures
Gaurav Tewari
Investor at Omega Venture Partners

Investors connected to Geoffrey in public investor directories — a warm-intro map.

Frequently asked questions

Who is Geoffrey Smith?
Geoffrey W. Smith combines biotech leadership as Alcea Therapeutics CEO with training physicians and scientists at Columbia, chairs Central European University, and founded Digitalis Commons for public-minded health innovation.
Where does Geoffrey Smith work?
Geoffrey Smith is Managing Partner at Digitalis Ventures and Board director at Grobio.
What does Geoffrey Smith invest in?
Geoffrey Smith invests in AI & Machine Learning, Biotech, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices.
What check size does Geoffrey Smith write?
Geoffrey Smith typically writes checks of $100K – $10M.
What companies has Geoffrey Smith invested in?
Investments tracked here include ARYx Therapeutics, Cara Therapeutics, Coferon, Elemental Machines, Girihlet, GRO Biosciences, Rejuvenate Bio, SchoolCare, TargAnox, Terray Therapeutics.
Where did Geoffrey Smith go to school?
Geoffrey Smith studied at University of Pennsylvania (Doctor of Law (J.D.)); Williams College (Bachelor of Arts (B.A.)).

Same school

Shared employers